MAPT and Alzheimer disease: These results are coherent with the observations of Mondragón-Rodrígez and colleagues (63), who suggest that tau phosphorylation in the early stages of AD might be a neuroprotective mechanism against Aβ-related hyperexcitability to suppress neuronal hyperexcitability.